Drug Shortage Report for TEVA-NITROFURANTOIN
| Report ID | 234873 |
| Drug Identification Number | 02231015 |
| Brand name | TEVA-NITROFURANTOIN |
| Common or Proper name | NITROFURANTOIN 50MG CAPS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | NITROFURANTOIN |
| Strength(s) | 50MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | J01XE |
| ATC description | OTHER ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-08-07 |
| Estimated end date | 2025-03-20 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-03-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v33 | 2025-03-13 | French | Compare |
| v32 | 2025-03-13 | English | Compare |
| v31 | 2025-02-28 | French | Compare |
| v30 | 2025-02-28 | English | Compare |
| v29 | 2025-02-20 | French | Compare |
| v28 | 2025-02-20 | English | Compare |
| v27 | 2025-02-13 | English | Compare |
| v26 | 2025-01-30 | French | Compare |
| v25 | 2025-01-30 | English | Compare |
| v24 | 2025-01-09 | French | Compare |
| v23 | 2025-01-09 | English | Compare |
| v22 | 2024-12-19 | French | Compare |
| v21 | 2024-12-19 | English | Compare |
| v20 | 2024-11-28 | French | Compare |
| v19 | 2024-11-28 | English | Compare |
| v18 | 2024-11-21 | French | Compare |
| v17 | 2024-11-21 | English | Compare |
| v16 | 2024-11-08 | French | Compare |
| v15 | 2024-11-08 | English | Compare |
| v14 | 2024-11-01 | French | Compare |